Actively Recruiting
Ultrasonographic Examination of Other Enthesitis Sites in Patients With Lateral Epicondylitis
Led by Marmara University · Updated on 2026-01-02
60
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Lateral epicondylitis (LE) is the tendinopathy of the common extensor tendon. Although exact etiology remains unclear, it is believed to be caused by overuse. Even though, genetics factor related to tendinopathies were defined accompanying tendinopathies in patients with LE is yet to be studied. Madrid sonographic enthesitis index (MASEI) is an ultrasound based scoring system, developed for the evaluation of the enthesitis. Initially developed for ankylosing spondylitis, its usage has also become widespread in other musculoskeletal diseases. The aim of this study is to calculate the MASEI score in patients diagnosed with LE, and compare it to healthy volunteers.
CONDITIONS
Official Title
Ultrasonographic Examination of Other Enthesitis Sites in Patients With Lateral Epicondylitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Tenderness with palpation at the lateral epicondyle
- Pain aggravated with resisted wrist extension
- Age between 18 and 60 years
You will not qualify if you...
- History of rheumatologic diseases
- History of elbow, knee or ankle surgery
- History of corticosteroid injections on elbow, knee or ankle
- History of peripheral neuropathy
- Acute trauma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Marmara University
Istanbul, Maltepe, Turkey (Türkiye), 34844
Actively Recruiting
Research Team
A
Arda Can Kasap, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here